TV Anchor Amy Robach Delivers Riveting Keynote on Breast Cancer Survival

Article

Breast cancer survivor and Good Morning America news anchor Amy Robach delivered a compelling keynote address at the 33rd Annual Miami Breast Cancer Conference®.

Amy Robach

Breast cancer survivor and Good Morning America news anchor Amy Robach delivered a compelling keynote address at the 33rd Annual Miami Breast Cancer Conference® that was as hard-hitting as it was emotional, slamming new US Preventive Services Task Force guidelines that push up the recommended age to 50 years for starting mammogram screening, and drawing moist eyes from the assembly of hundreds of breast cancer oncologists with her message of personal challenge and achievement.

“I thought I was that average woman in the US who doesn’t have to worry about getting the breast cancer test,” Robach said about her feelings in 2013 about mammogram screening. She was 40 years old, in excellent physical condition, and had no family history of breast cancer, leading her to believe that she was statistically in the safe zone. She had even conveniently “lost” a prescription from her OB-GYN to get a mammogram.

All those feelings of confidence and assumptions of immunity were turned upside down, she explained, when her Good Morning America producer began prodding her to set an example for women 40 years and above by getting a mammogram in the most public way, in a Times Square “mammovan” before a live television audience of 6 million.

“I guarantee you will save a life. How can you say ‘no’ to that?” Robach recalled her producer telling her. What Robach said she didn’t realize at that point was that the life she was saving would be her own. Discovery of a suspicious lump led to a stage II, ER-positive, breast cancer diagnosis, followed by a double mastectomy, which was her choice in order to achieve what she described as “peace of mind”—to drive the potential for recurrence as far away as possible.

Her keynote drew a standing ovation from the assembly of oncologists and other healthcare workers and was described by conference Program Chair Patrick I. Borgen, MD, as the most powerful event in all 33 years of the breast cancer conference.

For Robach, her decision to get a bilateral mastectomy turned out to be the right call, as during surgery in a last look, her physician discovered a previously unidentified tumor. “You were right but I was good,” her surgeon told her after the operation.

In her talk, Robach described how she rose above the disease and found deeper appreciation for life. And for a time, the patient became the advisor to the physicians in attendance, offering advice on lobbying Washington to achieve screening recommendations for women starting at age 40; how and when to approach patients about a positive diagnosis; how to discuss with patients whether to get genetic testing; and how to prepare them for coping with the ravages of disease and treatment.

Some of her strongest criticism was directed at her own news profession. Robach described having delivered some of those same headlines on screening guidelines without fully understanding the significance for that statistical subset of women who would miss out on opportunities to catch their own breast cancer early in development.

“I have some very persuasive colleagues to thank. They pushed me past those dangerous, seductive headlines that tell young women they don’t need to be tested for breast cancer if they’re at average risk for disease. We all know that family history only predicts a small percentage of breast cancer patients, so I don’t buy into this average risk security blanket that they’re pedaling. No one can tell me that a mammogram didn’t save my life.”

Her talk was at times infused with humor, as the gifted public speaker retold the events that led up to that very visible mammogram in Times Square. “My producer called me into her office and said ‘I have a very sensitive assignment for you,’” she recalled. “’We want an anchor to have the first-ever live mammogram. We want that anchor to be you!’ I said ‘No way, no how!’” Robach said. “I’m not going to do it! What’s next, a pap smear?! These are really personal things. I don’t want 6 million people watching me have a mammogram for the first time.”

When she got the news that they’d found something suspicious on her image, she still dragged her feet about getting it checked out.

“I wasn’t worried, I was annoyed. I remember the arguments against 40 year olds getting mammograms. False alarms; unnecessary tests, undue anxiety; and I thought, ‘here we go. This is exactly what they’re talking about, and now I’m experiencing it. Wow.’”

But she told her mother, who latched on and “started a daily barrage of texts: have you made your appointment? Have you made your appointment?” Her mother then got her dad to text her about following up, and her dad got her brother to text her. “That pretty much made me make the phone call,” she said about going in for further tests.

What followed was a highly emotional time as she learned the gravity of her situation and worried about how to break the news to her children. Her emotions at times got the best of her and it was difficult to absorb information and make decisions, which made it important for her to have family members around and doctors who were patient about explaining as many times as necessary until she understood what she needed to know.

“I desperately needed to know in those first few days that there was hope. I was frightened out of my mind.”

In those days and weeks after the operation, which was also high-profile, Robach was publicly lambasted for having made a decision “based on emotion, not on science.” In the end, though, “there’s nothing like getting a thank-you note from a woman for saving her life” by having encouraged her to get mammogram screening earlier, thereby uncovering a problem, she said.

Asked how the news of breast cancer should be delivered to patients, Robach said, “I think there’s no good way to do it. The radiologist asked me whether I wanted to come back the next day, when I could bring someone with me, but at that point I was so anxious. I needed to know no matter what.” She suggested that at least make sure the patient isn’t driving in a car at the time the news is broken.

In response to a question about how to get recommendations for screening changed, she said, “We have to speak up, we have to speak out. We have to continue to educate women about what their rights are; and yes, we have to lobby Congress, and do it better. Because it isn’t good enough.” As an example, she said she initially was asked to put some of the testing on her credit card because her insurance company turned her down. “I’m in a position where I can say OK, but how many other women can? That’s their rent, that’s food for their children.”

<<<

View more from the 33rd Annual Miami Breast Cancer Conference

Related Videos
Patrick I. Borgen, MD
Kari Hacker, MD, PhD, NYU Grossman School of Medicine
Janos L. Tanyi, MD, PhD, associate professor, Obstetrics and Gynecology, Hospital of the University of Pennsylvania
Reshma Lillaney Mahtani, DO
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center